| 标题 |
Efficacy and Safety of Immunotherapy Combined with Anlotinib as First-Line Treatment in Older NSCLC Patients with PD-L1 Expression |
| 网址 | |
| DOI |
10.2174/0115680096364469250113105648
doi
|
| 其它 |
期刊:Current Cancer Drug Targets 作者:Xiangyu Li; Wei Wang; Chunhua Xu; Yuan Qi 出版日期:2025-01-23 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)